Literature DB >> 15694496

The private demand for an AIDS vaccine in Thailand.

Chutima Suraratdecha1, Martha Ainsworth, Viroj Tangcharoensathien, Dale Whittington.   

Abstract

A contingent valuation survey of Thai adults revealed that private demand for a hypothetical AIDS vaccine that is safe, has no side effects, and lasts 10 years, rises with income, the lifetime risk of HIV infection and vaccine efficacy, and declines with vaccine price and respondent's age. Demand for both high (95%) and low (50%) efficacy AIDS vaccines is substantial. Nearly 80% of adults would agree to be vaccinated with a free vaccine. Government will have an important role to ensure that those at highest risk of HIV infection with low incomes have access to the vaccine and to reinforce other safe preventive behavior to prevent reductions in condom use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694496     DOI: 10.1016/j.healthpol.2004.05.005

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  5 in total

1.  HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach.

Authors:  Sung-Jae Lee; Ronald A Brooks; Peter A Newman; Danielle Seiden; Rassamee Sangthong; Naihua Duan
Journal:  AIDS Care       Date:  2008-11

2.  Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand.

Authors:  Pattara Leelahavarong; Yot Teerawattananon; Pitsaphun Werayingyong; Chutima Akaleephan; Nakorn Premsri; Chawetsan Namwat; Wiwat Peerapatanapokin; Viroj Tangcharoensathien
Journal:  BMC Public Health       Date:  2011-07-05       Impact factor: 3.295

3.  Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives.

Authors:  Robert Hecht; Chutima Suraratdecha
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

4.  HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.

Authors:  April M Young; Ralph J DiClemente; Daniel S Halgin; Claire E Sterk; Jennifer R Havens
Journal:  BMC Public Health       Date:  2014-05-30       Impact factor: 3.295

5.  The Willingness to Pay for Vaccination against Tick-Borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden.

Authors:  Daniel Slunge
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.